IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $22,185,000 | +149.5% | 260,905 | +4.0% | 7.21% | +181.1% |
Q2 2020 | $8,892,000 | +9067.0% | 250,905 | +4866.4% | 2.57% | +6009.5% |
Q1 2019 | $97,000 | -91.7% | 5,052 | -93.9% | 0.04% | -92.8% |
Q4 2018 | $1,174,000 | -68.3% | 82,254 | -53.8% | 0.58% | -61.7% |
Q3 2018 | $3,708,000 | -14.4% | 178,000 | -2.7% | 1.52% | -24.9% |
Q2 2018 | $4,332,000 | +5.6% | 183,000 | -34.9% | 2.03% | +1.6% |
Q1 2018 | $4,104,000 | -16.5% | 280,900 | -7.6% | 2.00% | -24.5% |
Q4 2017 | $4,913,000 | -23.7% | 304,000 | -34.0% | 2.65% | -33.8% |
Q3 2017 | $6,437,000 | +14.3% | 460,451 | -27.8% | 4.00% | -0.5% |
Q2 2017 | $5,631,000 | +244.6% | 637,700 | +152.5% | 4.02% | +190.7% |
Q1 2017 | $1,634,000 | -20.4% | 252,574 | -54.9% | 1.38% | -23.4% |
Q4 2016 | $2,054,000 | +11.5% | 559,674 | -1.3% | 1.80% | +40.7% |
Q3 2016 | $1,842,000 | -2.6% | 566,796 | -30.5% | 1.28% | -14.4% |
Q2 2016 | $1,891,000 | – | 815,000 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |